Literature DB >> 26635352

Protein kinase Cζ exhibits constitutive phosphorylation and phosphatidylinositol-3,4,5-triphosphate-independent regulation.

Irene S Tobias1, Manuel Kaulich2, Peter K Kim3, Nitya Simon4, Estela Jacinto3, Steven F Dowdy2, Charles C King5, Alexandra C Newton6.   

Abstract

Atypical protein kinase C (aPKC) isoenzymes are key modulators of insulin signalling, and their dysfunction correlates with insulin-resistant states in both mice and humans. Despite the engaged interest in the importance of aPKCs to type 2 diabetes, much less is known about the molecular mechanisms that govern their cellular functions than for the conventional and novel PKC isoenzymes and the functionally-related protein kinase B (Akt) family of kinases. Here we show that aPKC is constitutively phosphorylated and, using a genetically-encoded reporter for PKC activity, basally active in cells. Specifically, we show that phosphorylation at two key regulatory sites, the activation loop and turn motif, of the aPKC PKCζ in multiple cultured cell types is constitutive and independently regulated by separate kinases: ribosome-associated mammalian target of rapamycin complex 2 (mTORC2) mediates co-translational phosphorylation of the turn motif, followed by phosphorylation at the activation loop by phosphoinositide-dependent kinase-1 (PDK1). Live cell imaging reveals that global aPKC activity is constitutive and insulin unresponsive, in marked contrast to the insulin-dependent activation of Akt monitored by an Akt-specific reporter. Nor does forced recruitment to phosphoinositides by fusing the pleckstrin homology (PH) domain of Akt to the kinase domain of PKCζ alter either the phosphorylation or activity of PKCζ. Thus, insulin stimulation does not activate PKCζ through the canonical phosphatidylinositol-3,4,5-triphosphate-mediated pathway that activates Akt, contrasting with previous literature on PKCζ activation. These studies support a model wherein an alternative mechanism regulates PKCζ-mediated insulin signalling that does not utilize conventional activation via agonist-evoked phosphorylation at the activation loop. Rather, we propose that scaffolding near substrates drives the function of PKCζ.
© 2016 Authors; published by Portland Press Limited.

Entities:  

Keywords:  atypical protein kinase C; insulin; mTOR complex; phosphatidylinositol signalling; phosphatidylserine; phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 26635352      PMCID: PMC4888060          DOI: 10.1042/BJ20151013

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  91 in total

1.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

2.  Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter.

Authors:  Maya T Kunkel; Qiang Ni; Roger Y Tsien; Jin Zhang; Alexandra C Newton
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

3.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

4.  PKC-zeta mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes.

Authors:  Gautam Bandyopadhyay; Mini P Sajan; Yoshinori Kanoh; Mary L Standaert; Michael J Quon; Rene Lea-Currie; Anindita Sen; Robert V Farese
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

5.  Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta.

Authors:  G Bandyopadhyay; M L Standaert; M P Sajan; L M Karnitz; L Cong; M J Quon; R V Farese
Journal:  Mol Endocrinol       Date:  1999-10

Review 6.  Protein kinase C: poised to signal.

Authors:  Alexandra C Newton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

Review 7.  Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions.

Authors:  Takaaki Hirai; Kazuhiro Chida
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

8.  Regulation of protein kinase C zeta by PI 3-kinase and PDK-1.

Authors:  M M Chou; W Hou; J Johnson; L K Graham; M H Lee; C S Chen; A C Newton; B S Schaffhausen; A Toker
Journal:  Curr Biol       Date:  1998-09-24       Impact factor: 10.834

9.  Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.

Authors:  Robert V Farese; Mini P Sajan; Hong Yang; Pengfei Li; Steven Mastorides; William R Gower; Sonali Nimal; Cheol Soo Choi; Sheene Kim; Gerald I Shulman; C Ronald Kahn; Ursula Braun; Michael Leitges
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

10.  The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.

Authors:  R B Pearson; P B Dennis; J W Han; N A Williamson; S C Kozma; R E Wettenhall; G Thomas
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

View more
  22 in total

Review 1.  Protein kinase C as a tumor suppressor.

Authors:  Alexandra C Newton
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

2.  Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.

Authors:  Julia A Callender; Yimin Yang; Gema Lordén; Natalie L Stephenson; Alexander C Jones; John Brognard; Alexandra C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

Review 3.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

4.  Short-term heat stress altered metabolism and insulin signaling in skeletal muscle.

Authors:  Shanthi Ganesan; Corey M Summers; Sarah C Pearce; Nicholas K Gabler; Rudy J Valentine; Lance H Baumgard; Robert P Rhoads; Joshua T Selsby
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

5.  Role of Protein Kinase C in Immune Cell Activation and Its Implication Chemical-Induced Immunotoxicity.

Authors:  Emanuela Corsini; Erica Buoso; Valentina Galbiati; Marco Racchi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.

Authors:  Taketoshi Kajimoto; Alisha D Caliman; Irene S Tobias; Taro Okada; Caila A Pilo; An-Angela N Van; J Andrew McCammon; Shun-Ichi Nakamura; Alexandra C Newton
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

Review 7.  Polyphenol compounds and PKC signaling.

Authors:  Joydip Das; Rashmi Ramani; M Olufemi Suraju
Journal:  Biochim Biophys Acta       Date:  2016-06-29

Review 8.  Molecular Control of Atypical Protein Kinase C: Tipping the Balance between Self-Renewal and Differentiation.

Authors:  Michael L Drummond; Kenneth E Prehoda
Journal:  J Mol Biol       Date:  2016-03-16       Impact factor: 5.469

9.  Protein Scaffolds Control Localized Protein Kinase Cζ Activity.

Authors:  Irene S Tobias; Alexandra C Newton
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

10.  HIF and HOIL-1L-mediated PKCζ degradation stabilizes plasma membrane Na,K-ATPase to protect against hypoxia-induced lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Markus A Queisser; Patricia L Brazee; Lynn C Welch; Kishore R Anekalla; Guofei Zhou; Olga Vagin; Alexander V Misharin; G R Scott Budinger; Kazuhiro Iwai; Aaron J Ciechanover; Jacob I Sznajder
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.